This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taddei, S. Articles by Salvetti, A. Search for Related Content PubMed PubMed Citation Articles by Taddei, S. Articles by Salvetti, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure

(Hypertension. 1997;30:1606-1612.)
© 1997 American Heart Association, Inc.

Articles

Lacidipine Restores Endothelium-Dependent Vasodilation in Essential Hypertensive Patients

Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Stefano Uleri; Armando Magagna; ; Antonio Salvetti

From the I Clinica Medica, University of Pisa, Pisa, Italy.

Correspondence to Dr Stefano Taddei, I Clinica Medica, University of Pisa, Via Roma, 67, 56100 Pisa, Italy.

Abstract Essential hypertension is characterized by impaired endothelium-dependent vasodilation. The present study was designed to test whether antihypertensive treatment with the calcium antagonist lacidipine can improve endothelium-dependent vasodilation in essential hypertensive patients. In 12 normotensive subjects (mean age, 47.8±8.6 years; blood pressure, 118.6±4.2/76.7±3.9 mm Hg) and 19 hypertensive patients (mean age, 49.4±10.2 years; blood pressure; 153.5±13.3/101.3±6.4 mm Hg), we studied forearm blood flow modifications (strain-gauge plethysmography) induced by intrabrachial infusion of acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 µg/100 mL per minute) and bradykinin (5, 15, and 50 ng/100 mL per minute), two endothelium-dependent vasodilators that act through different receptors and signal transduction pathways, and sodium nitroprusside (1, 2, and 4 µg/100 mL per minute), an endothelium-independent vasodilator. In essential hypertensive patients, vascular reactivity was repeated during prolonged (8 weeks of oral treatment at 6 mg/d) lacidipine administration and 2 weeks after withdrawal of chronic (32-week) treatment. Hypertensive patients showed significantly (P<.01) blunted vasodilation in response to acetylcholine (vascular resistance, 31.5±4.9 to 7.6±2.4 SU) and bradykinin (vascular resistance, 32.3±5.8 to 8.5±3.0 SU) compared with control subjects (vascular resistance: acetylcholine, 24.3±3.9 to 3.7±1.2 SU; bradykinin, 24.7±0.4 to 4.1±1.3 SU), whereas the response to sodium nitroprusside was similar. After either 8 or 32 weeks of lacidipine treatment, the vasodilation in response to acetylcholine (30.6±7.7 to 5.7±1.5 and 34.3±6.6 to 5.9±1.9 SU, respectively) and bradykinin (31.3±7.2 to 6.4±1.6 and 33.7±5.4 to 6.1±1.5 SU, respectively), but not to sodium nitroprusside, proved to be significantly (P<.05) increased compared with baseline. In essential hypertensive patients, oral treatment with lacidipine increased forearm vasodilation in response to acetylcholine and bradykinin, suggesting that this drug can improve endothelial function in patients with essential hypertension.

Key Words: endothelium • acetylcholine • bradykinin • hypertension • essential

This article has been cited by other articles:

				I. Sudano, A. Virdis, S. Taddei, L. Spieker, R. Corti, G. Noll, A. Salvetti, and T. F. Luscher Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension Hypertension, February 1, 2007; 49(2): 285 - 290. [Abstract] [Full Text] [PDF]

				M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]

				W. Ridderstrale, E. Ulfhammer, S. Jern, and T. Hrafnkelsdottir Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy Hypertension, April 1, 2006; 47(4): 686 - 691. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin and R. M. Touyz From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446. [Full Text] [PDF]

				G. S. Stokes, E. S. Barin, and K. L. Gilfillan Effects of Isosorbide Mononitrate and AII Inhibition on Pulse Wave Reflection in Hypertension Hypertension, February 1, 2003; 41(2): 297 - 301. [Abstract] [Full Text] [PDF]

				M. Rathaus and J. Bernheim Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension Nephrol. Dial. Transplant., February 1, 2002; 17(2): 216 - 221. [Abstract] [Full Text] [PDF]

				M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1083 - 1088. [Abstract] [Full Text] [PDF]

				F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, A. Scozzafava, A. Ferraro, M. Chello, P. Mastroroberto, P. Verdecchia, et al. Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients Circulation, July 10, 2001; 104(2): 191 - 196. [Abstract] [Full Text] [PDF]

				L. Haegeli, K. Quitzau, T.F. Luscher, and Steering Committee and the Investigators of the EN From endothelial dysfunction to clinical events Concept and update on the ENCORE trials Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B12 - B19. [Abstract] [PDF]

				P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, and T. Godfraind Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats Hypertension, April 1, 2001; 37(4): 1124 - 1128. [Abstract] [Full Text] [PDF]

				S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, S. Favilla, A. Pompella, and A. Salvetti Restoration of Nitric Oxide Availability After Calcium Antagonist Treatment in Essential Hypertension Hypertension, March 1, 2001; 37(3): 943 - 948. [Abstract] [Full Text] [PDF]

				J.-G. Wang, J. A. Staessen, L. Gong, L. Liu, and for the Systolic Hypertension in China Collaborat Chinese Trial on Isolated Systolic Hypertension in the Elderly Arch Intern Med, January 24, 2000; 160(2): 211 - 220. [Abstract] [Full Text] [PDF]

				J. Tuomilehto, D. Rastenyte, W. H. Birkenhager, L. Thijs, R. Antikainen, C. J. Bulpitt, A. E. Fletcher, F. Forette, A. Goldhaber, P. Palatini, et al. Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension N. Engl. J. Med., March 4, 1999; 340(9): 677 - 684. [Abstract] [Full Text] [PDF]

				M. L. Muiesan, M. Salvetti, C. Monteduro, D. Rizzoni, R. Zulli, C. Corbellini, C. Brun, and E. Agabiti-Rosei Effect of Treatment on Flow-Dependent Vasodilation of the Brachial Artery in Essential Hypertension Hypertension, January 1, 1999; 33(1): 575 - 580. [Abstract] [Full Text] [PDF]